This observation opens the way to further investigations in order to understand the functional impact of NRP-1 on the control of the EGFR pathway, activated in response to chemotherapy, and the effect of NRP-1 targeting as a novel strategy for personalized treatments in HNSCC. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.